These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4903158)

  • 1. The relation of K antigens to the complement sensitivity of strains of Escherichia coli.
    Glynn AA; Howard CJ
    J Gen Microbiol; 1969 Aug; 57(3):18. PubMed ID: 4903158
    [No Abstract]   [Full Text] [Related]  

  • 2. Bactericidal activity of bovine fetal serum against smooth and rough strains of Escherichia coli.
    Barta O; Barta V; Ingram DG; Hubbert WT
    Am J Vet Res; 1972 Apr; 33(4):731-40. PubMed ID: 4552948
    [No Abstract]   [Full Text] [Related]  

  • 3. The serum bactericidal reaction. 3. Antibody and complement requirements for killing a rough Escherichia coli.
    Goldman JN; Ruddy S; Austen KF; Feingold DS
    J Immunol; 1969 Jun; 102(6):1379-87. PubMed ID: 4891549
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serum resistance of Escherichia coli in chronic pyelonephritis. 1. Serum resistance in the human serum pool].
    Falkenhagen U; Handschuck I; Ulisko IN; Ratiner YuA ; Nimmich W; Zingler G; Naumann G
    Z Urol Nephrol; 1984 Jul; 77(7):391-400. PubMed ID: 6385542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic and capsular factors of coliforms which affect resistance to bovine serum bactericidal activity.
    Ward GE; Sebunya TK
    Am J Vet Res; 1981 Nov; 42(11):1937-40. PubMed ID: 7039431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a quantitative microtiter method, a quantitative automated method, and the plate-count method for determining microbial complement resistance.
    Lee MD; Wooley RE; Brown J; Spears KR; Nolan LK; Shotts EB
    Avian Dis; 1991; 35(4):892-6. PubMed ID: 1786019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of cefotaxime and normal human serum on bactericidal activity against urinary strains of Escherichia coli with capsular antigen K1.
    Franiczek R; Jankowski S
    Acta Microbiol Pol; 1993; 42(3-4):243-50. PubMed ID: 7516615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of anti-phage antibody by passive hemagglutination. II. Early antibodies produced in vivo or in vitro.
    Walker WS; Fishman M; Adler FL
    J Immunol; 1971 Oct; 107(4):953-6. PubMed ID: 4937471
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of acriflavine on complement sensitive and resistant strains of Escherichia coli and on complement resistant mutants.
    Glynn AA; Priest CM
    Immunology; 1970 Jan; 18(1):19-22. PubMed ID: 4903984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal activity of conventional and germfree pig serum against smooth and rough strains of Escherichia coli.
    Barta O; Barta V; Miniats OP; Ingram DG
    Am J Vet Res; 1971 Jul; 32(7):1077-82. PubMed ID: 4932707
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of bactericidal activity in patients with impaired immunity].
    Krystůfková O; Seidlová A; Haskovcová H; Fucíková T
    Sb Lek; 1984 Jun; 86(5-6):186-90. PubMed ID: 6387879
    [No Abstract]   [Full Text] [Related]  

  • 12. An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action.
    Vaara M; Viljanen P; Vaara T; Mäkelä PH
    J Immunol; 1984 May; 132(5):2582-9. PubMed ID: 6325539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lesions in Escherichia coli cell walls caused by the action of mouse complement.
    Medhurst FA; Glynn AA; Dourmashkin RR
    Immunology; 1971 Apr; 20(4):441-50. PubMed ID: 4928548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K antigens of Escherichia coli and renal involvement in urinary tract infections.
    Glynn AA; Howard CJ; Brumfitt W
    J Med Microbiol; 1971 May; 4(2):Pi-Pii. PubMed ID: 4936567
    [No Abstract]   [Full Text] [Related]  

  • 16. Complement-independent adherence of Escherichia coli to complement receptors in vitro.
    Fine DP; Harper BL; Carpenter ED; Davis CP; Cavallo T; Guckian JC
    J Clin Invest; 1980 Sep; 66(3):465-72. PubMed ID: 6105165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of plasmids of various incompatibility groups on the serum sensitivity of Escherichia coli K 12].
    Falkenhagen U; Tschäpe H; Naumann G; Zingler G
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Nov; 253(2):164-74. PubMed ID: 6762011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sensitivity to complement of strains of Escherichia coli related to their K antigens.
    Glynn AA; Howard CJ
    Immunology; 1970 Mar; 18(3):331-46. PubMed ID: 4986073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of the Fc and C3 receptors in the phagocytosis and killing of bacteria by human phagocytes.
    Horwitz MA
    J Reticuloendothel Soc; 1980 Dec; 28(Suppl):17s-26s. PubMed ID: 7003137
    [No Abstract]   [Full Text] [Related]  

  • 20. Restricted complement activation by Escherichia coli with the K-1 capsular serotype: a possible role in pathogenicity.
    Stevens P; Huang SN; Welch WD; Young LS
    J Immunol; 1978 Dec; 121(6):2174-80. PubMed ID: 363940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.